Three heart medications in short supply in Canada

L Eggertson - 2014 - Can Med Assoc
News “the most toxic” antiarrhythmic with “multiple side effects.” Many of Crystal's patients
are forced to go to multiple compounding pharmacies which have some propafenone that …

To the Editor—Flecainide and propafenone: Good twins for premature ventricular contractions' killing but not exactly superimposable

A Capucci, G Ciliberti, F Guerra - Heart Rhythm, 2018 - heartrhythmjournal.com
We have read with great interest the article by Hyman et al 1 dealing with successful use of
class IC antiarrhythmic drugs (IC-AADs) in patients with premature ventricular contraction …

[CITATION][C] INTERNATIONAL: FDA issues drug warning NEWS DIGEST.

A Michaels - The Financial Times, 2000 - go.gale.com
The FDA said 70 people had died while on the drug and an analysis of 200 other patients
with side-effects showed incidences of heart rhythm disorders. About 85 per cent of the 270 …

[CITATION][C] Flecainide is Effective in Supraventricular Arrhythmias

H Crijns, LM Wijk, WH Gilst, J Herre Kingma… - therapy, 1988 - Springer
More effective, easily administered and less toxic antiarrhythmic drugs are required for
children refractory to conventional therapy so a study was conducted to assess the clinical …

Generic antiarrhythmics are not therapeutically equivalent for the treatment of tachyarrhythmias1

JA Reiffel, PR Kowey - American Journal of Cardiology, 2000 - ajconline.org
Antiarrhythmic drugs (AAD) have been the mainstay of arrhythmia therapy. For serious
arrhythmias, AAD failure may result in death. If AAD levels fall below the minimum effective …

Reply to the Editor—Flecainide and Propafenone: Good twins for premature ventricular contractions' killing but not exactly superimposable

DS Frankel - Heart Rhythm, 2018 - heartrhythmjournal.com
We have read with great interest the article by Hyman et al 1 dealing with successful use of
class IC antiarrhythmic drugs (IC-AADs) in patients with premature ventricular contraction …

Trends in antiarrhythmic drug use in Denmark over 19 years

CB Poulsen, M Damkjær, B Løfgren… - The American Journal of …, 2020 - Elsevier
Antiarrhythmic drugs are widely used in the treatment of supraventricular and ventricular
arrhythmias. Yet, nationwide long-term utilization trends remain unexplored. We examined …

[CITATION][C] Flecainide overdose

C Rogers - Reactions, 1994 - Springer
Two patients died after ingesting overdoses of the antiarrhythmic medication, flecainide
[Tambocor®]. The first patient, a 33-year-old woman, had a history of depression. She was …

P. 3. Basic Science, Sudden Death Risk Stratification and Ventricular Arrhythmias: P. 3.22 Antiarrhythmics Drugs: Evaluation of Prescriptions in Venice and Veneto

A Dorigo, N Burlon - Europace, 2005 - elibrary.ru
Background and Objective The aim of this study is to observe the prescriptions of
antiarrhythmics drugs (AD) and estimate their fluctuation; it allows quantifying the amount of …

Beating to Its Own Drum; Flecainide Toxicity and Cardiogenic Shock in a Patient With Dual-Chamber Pacemaker

K Gooding, R Salunke, G Fiscus… - … REACTIONS IN THE …, 2024 - atsjournals.org
Introduction: Flecainide is a class IC antiarrhythmic agent indicated for treatment of
supraventricular arrhythmias. It has the potential to induce proarrhythmic events, even when …